Multiple sclerosis is a devastating disease that induces the body's own immune system to eat away at the central nervous system, slowly robbing patients of their physical mobility. It is also mysterious. Despite years of research, the cause remains elusive, and treatments are few and far between.
Progress is slow, but measurable. The study of clusters of cases in Canada is starting to reveal the complicated interactions between genetics, geography and a common viral infection that may lie behind the disease (see page S4). And new treatments, many based on existing drugs, are starting to show promise for the more debilitating progressive form of the disease, which has until recently been largely ignored and forgotten (S7). Leaders in the field are calling on researchers to take more risks and develop new kinds of clinical trial to test different combinations of drugs to treat progressive multiple sclerosis (S10).
A drastic form of treatment that eliminates a patient's immune system and replaces it with fresh stem cells (S11) is offering hope. But many doctors worry that it is too dangerous for widespread use, and it is already attracting unethical and unlicensed imitators.
Until a blockbuster drug treatment is found, patients have to manage their disease. A variety of diets have been developed, aimed at helping to control the symptoms, and they are now finally getting the scientific scrutiny they deserve, despite the difficulties of applying rigorous clinical-trial standards to eating habits (S13). With perseverance, imagination and a bit of luck, progress on treating and curing multiple sclerosis could soon move faster than ever.
This Outlook has been supported by a grant from F. Hoffmann-La Roche Ltd, which has had no control over the editorial content of this activity.
Author information
Rights and permissions
About this article
Cite this article
Owens, B. Multiple sclerosis. Nature 540, S1 (2016). https://doi.org/10.1038/540S1a
Published:
Issue Date:
DOI: https://doi.org/10.1038/540S1a
This article is cited by
-
Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials
BMC Medicine (2024)
-
Potential application of hydrogel to the diagnosis and treatment of multiple sclerosis
Journal of Biological Engineering (2022)
-
A Novel Role of Nogo Proteins: Regulating Macrophages in Inflammatory Disease
Cellular and Molecular Neurobiology (2022)
-
Regulated cell death: discovery, features and implications for neurodegenerative diseases
Cell Communication and Signaling (2021)